
Timken (TKR) reported quarterly revenue of US$1.26b, up 7.5% year on year and ahead of expectations on both revenue and EBITDA, yet the stock dropped 18.2% after the release.
Timken’s sharp post earnings drop came after a strong run, with the 1 year total shareholder return at 66.3% and the 5 year total shareholder return at 75.1%. The share price is still up 34.6% year to date, suggesting that recent momentum has faded as investors reassess execution risks and future growth expectations.
Scan the industrial space for other stocks where execution, balance sheets and pricing power align by reviewing our curated list of list of solid balance sheet and fundamentals (25 results).
Timken just paired a strong operational update with a sharp share price reset. The business looks solid on paper. The real test now is whether the current valuation fairly reflects that strength.
Timken’s widely followed narrative pegs fair value at about $146.47, above the last close of $116.12. The recent selloff still leaves a valuation gap that hinges on execution of its margin and portfolio plans.
The company is reshaping its portfolio by exiting about US$150 million of low return automotive OEM revenue by 2028 and has completed the sale of its belts business. These actions are expected to add roughly 150 bps to Engineered Bearings margins and more than 200 bps to Industrial Motion margins, which points to structurally higher net margins.
See why 4 investors see Timken as 21% undervalued.
Result: Fair Value of $146.47 (UNDERVALUED)
Still, the Timken story can break if organic growth stays muted, while mix and cost pressures in areas like solar, wind and aerospace keep squeezing profitability.
Find out about the key risks to this Timken narrative.
Mixed about whether Timken’s reset is a chance or a warning? Act while the stock is in flux and weigh both sides with 3 key rewards and 3 important warning signs.
Timken’s reset is one stock story. Portfolio results usually come from finding a few more ideas that fit your risk comfort and return goals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com